Crossmark Global Holdings, Inc. Fulgent Genetics, Inc. Transaction History

Crossmark Global Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 10, 2022	SELL	$77.3 - $105.0 $1.14 Million - $1.54 Million	-14,710 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$74.87 - $110.87 $1.1 Million - $1.63 Million	14,710 New	14,710 $1.32 Million
Q3 2021 Oct 13, 2021	SELL	$74.87 - $110.87 $1.16 Million - $1.71 Million	-15,440 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$66.8 - $100.45 $13,360 - $20,090	-200 Reduced 1.28%	15,440 $1.42 Million
Q1 2021 Apr 15, 2021	BUY	$59.3 - $183.85 $42,103 - $130,533	710 Added 4.76%	15,640 $1.51 Million
Q4 2020 Jan 14, 2021	BUY	$31.01 - $52.1 $462,979 - $777,853	14,930 New	14,930 $778,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.